A randomized, double blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group - Lusher, JM; Roberts, HR; Davignon, G (Haemophilia, 1998)
et al.